Edgewise Therapeutics Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
14.28
-0.29
(-1.99%)
Volume:
898,715
52 week range:
10.60 - 38.12
Market Cap:
1.502B
Company Description:
Edgewise Therapeutics, Inc. develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy.